REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
REVELATION BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.29+2.80 (+577.76%)
Close on Oct 19, 2026
- Market cap
- $12.58M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 20, 2026 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Jan 28, 2026 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Jul 7, 2025 | 1-for-3 reverse | Earlier per-share figures multiplied by 3 |
| Jan 28, 2025 | 1-for-16 reverse | Earlier per-share figures multiplied by 16 |
| Mar 22, 2024(first seen in filings) | 1-for-7.5 reverse | Earlier per-share figures multiplied by 7.5 |
| Jan 25, 2024 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Feb 1, 2023 | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |
| Jan 30, 2023 | 1-for-34 reverse | Earlier per-share figures multiplied by 34 |